Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | OCGN | Common Stock | Tax liability | -$985 | -842 | -0.24% | $1.17 | 348K | Sep 16, 2024 | Direct |
Chief Scientific Officer, Head of Research, Development and Medical